| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.35 | 8e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |